Drug:
Reaction: ANAEMIA
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26861930 |
US |
40 | 2 |
Muscle rupture, Anaemia, Blood iron decreased, Rash vesicular, Illness, Rash, Creatine kinase increased, Vomiting, Abdominal discomfort, Alopecia, Blood alkaline phosphatase increased, Product dose omission issue, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 502 | 26862039 |
CN |
48 | 1 |
Anaemia, Cardiac disorder, Dizziness, Asthenia, Suspected off label use, |
||||
LINEZOLID, |
||||
| 503 | 26862146 |
83 | 2 | |
Death, Anaemia, Haemorrhage, Urogenital haemorrhage, Haematoma, Epistaxis, |
||||
ACALABRUTINIB, OBINUTUZUMAB, SITAGLIPTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 504 | 26862278 |
EU |
57 | 1 |
Neutropenia, Immune-mediated hypothyroidism, Anaemia, Oedema peripheral, Mucosal inflammation, Anaemia, Neutropenia, Anaemia, Neutropenia, Anaemia, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, FUROSEMIDE, SPIRONOLACTONE, |
||||
| 505 | 26862371 |
SO |
3 | 2 |
Loss of consciousness, Drug-induced liver injury, Altered state of consciousness, Analgesic drug level increased, Inflammatory marker increased, Anaemia, Generalised tonic-clonic seizure, Hepatic enzyme increased, Product administration issue, Subacute sclerosing panencephalitis, Hypotonia, Rales, Oxygen saturation normal, Blood pressure abnormal, Tachycardia, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 506 | 26862481 |
US |
2 | |
Anaemia, |
||||
TILDRAKIZUMAB-ASMN, |
||||
| 507 | 26862559 |
EU |
71 | 1 |
Hypogammaglobulinaemia, Bence Jones proteinuria, Bone lesion, Anaemia, Light chain analysis increased, Proteinuria, Hyperferritinaemia, |
||||
LENALIDOMIDE, ISATUXIMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BORTEZOMIB, SERTRALINE, DAPAGLIFLOZIN, |
||||
| 508 | 26852677 |
IR |
15 | 1 |
Product ineffective for unapproved use, Myelosuppression, Thrombocytopenia, Anaemia, Suspected off label use, |
||||
ETANERCEPT, ETANERCEPT, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MEROPENEM, MEROPENEM, FLUCONAZOLE, FLUCONAZOLE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HUMAN IMMUNOGLOBULIN G, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, ACYCLOVIR, ACYCLOVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 509 | 26852838 |
TH |
49 | 2 |
Malignant neoplasm progression, Dizziness, Nausea, Vomiting, Headache, Nausea, Leukopenia, Anaemia, |
||||
PEMBROLIZUMAB, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 510 | 26853039 |
US |
2 | |
Tuberculosis, Asthenia, Anaemia, |
||||
RISANKIZUMAB-RZAA, |
||||
| 511 | 26853071 |
US |
1 | |
Diabetes mellitus, Condition aggravated, Diarrhoea, Rash, Blood glucose abnormal, Decreased appetite, Insomnia, Memory impairment, Ageusia, Anaemia, Pain, Neuralgia, |
||||
OSIMERTINIB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BENZONATATE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, PREDNISONE, INSULIN GLARGINE, INSULIN ASPART, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, FINASTERIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ONDANSETRON HYDROCHLORIDE, ERGOCALCIFEROL, PROCHLORPERAZINE MALEATE, |
||||
| 512 | 26853656 |
EU |
80 | 1 |
Sepsis, Thrombosis, Pulmonary embolism, Pneumonia, Bacterial infection, Drug hypersensitivity, Dyspnoea, Iron deficiency, Anaemia, Blood cholesterol increased, Blood uric acid increased, Stress, Hyponatraemia, Blood phosphorus increased, Somnolence, Activated partial thromboplastin time prolonged, Iron deficiency anaemia, Appendicitis, Appendicolith, Aortic stenosis, Ascites, Abdominal distension, Abdominal pain, Bacteroides infection, Blood calcium increased, Hyperlipidaemia, Blood creatinine increased, Blood test abnormal, Cardiogenic shock, Constipation, Chronic obstructive pulmonary disease, Condition aggravated, Diabetes mellitus, Drug hypersensitivity, Drug intolerance, Drug ineffective, End stage renal disease, General physical health deterioration, Gout, Hypophosphataemia, Hypertension, Inappropriate schedule of product administration, Intentional product misuse, Incorrect route of product administration, Lower respiratory tract infection, Lung opacity, Multiple organ dysfunction syndrome, Musculoskeletal stiffness, Myasthenia gravis, Nausea, Neuralgia, Oedema peripheral, Off label use, Pleural effusion, Dry mouth, Sleep disorder, Swelling, Troponin increased, Ulcer, Ventricular fibrillation, Vomiting, Somnolence, Total lung capacity decreased, Intentional product misuse, |
||||
AMLODIPINE, AMLODIPINE, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, CEFTRIAXONE, CEFTRIAXONE SODIUM, CEFTRIAXONE, CEFTRIAXONE SODIUM, GABAPENTIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, RAMIPRIL, SIMVASTATIN, SIMVASTATIN, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR ACID, OSELTAMIVIR, INSULIN DEGLUDEC, VITAMIN E, SODIUM FERRIC GLUCONATE COMPLEX, SODIUM FERRIC GLUCONATE COMPLEX, SODIUM FERRIC GLUCONATE COMPLEX, SODIUM FERRIC GLUCONATE COMPLEX, SODIUM CITRATE, SODIUM CITRATE, MAGNESIUM CARBONATE, HYDROMORPHONE HYDROCHLORIDE, HEPARIN SODIUM AND DEXTROSE, HEPARIN SODIUM AND DEXTROSE, SODIUM FERRIC GLUCONATE COMPLEX, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALLANTOIN, MEDICINAL MASSAGE OIL, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALLANTOIN, MEDICINAL MASSAGE OIL, ALUMINUM HYDROXIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMMONIUM CHLORIDE, DARBEPOETIN ALFA, ASCORBIC ACID, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, BISMUTH SUBNITRATE, BIOTIN, BIOTIN, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISMUTH SUBNITRATE, BISMUTH SUBSALICYLATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CALCIUM CARBONATE, ANTACID, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, CALCIUM GLUCONATE, CHLORPHENIRAMINE MALEATE, CITRIC ACID, HYDROCORTISONE, DEXTROSE MONOHYDRATE, DEXTROSE, DALTEPARIN SODIUM, DALTEPARIN SODIUM, DARBEPOETIN ALFA, DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, DEXPANTHENOL, DEXTROSE MONOHYDRATE, DEXTROSE, DOBUTAMINE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, ERGOCALCIFEROL, SODIUM FERRIC GLUCONATE COMPLEX, INSULIN ASPART INJECTION, INSULIN ASPART, FISH OIL, FLUTICASONE FUROATE, LANTHANUM CARBONATE, LANTHANUM CARBONATE, DALTEPARIN SODIUM, HEPARIN SODIUM AND DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, HEPARIN SODIUM, HEPARIN SODIUM, HYDROCORTISONE ACETATE, HORSE CHESTNUT, INSULIN ASPART, IRON, LANTHANUM CARBONATE, LANTHANUM CARBONATE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, PENTOSAN POLYSULFATE SODIUM, MAGNESIUM OXIDE, MANNITOL, MELATONIN, FERRIC DERISOMALTOSE, NATAMYCIN, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, PHYTONADIONE, ASIAN GINSENG, POTASSIUM CHLORATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LANSOPRAZOLE, PROPYLENE GLYCOL, PROPYLENE GLYCOL, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, SODIUM FERRIC GLUCONATE COMPLEX, METHYLCELLULOSE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, SIMVASTATIN, SIMVASTATIN, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, SODIUM CITRATE, SODIUM PHOSPHATE, SUCROSE, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR PHOSPHATE, TITANIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, INSULIN DEGLUDEC, UMECLIDINIUM, PHYTONADIONE, VASOPRESSIN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, |
||||
| 513 | 26854001 |
EU |
73 | 1 |
Neutropenia, Leukopenia, Condition aggravated, Anaemia, Lymphopenia, Thrombocytopenia, Inappropriate schedule of product administration, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 514 | 26854039 |
EU |
72 | 2 |
Thrombocytopenia, Pneumonia escherichia, Neutropenia, Respiratory distress, Anaemia, |
||||
DOXORUBICIN, PREDNISONE, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 515 | 26854256 |
JP |
40 | 2 |
Neutropenia, Anaemia, |
||||
DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, ETOPOSIDE, ETOPOSIDE, CISPLATIN, CISPLATIN, MITOTANE, |
||||
| 516 | 26854411 |
EU |
60 | 1 |
Gastric ulcer haemorrhage, Anaemia, |
||||
ETOPOSIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, IFOSFAMIDE, IFOSFAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYTARABINE, RITUXIMAB, PREDNISONE, |
||||
| 517 | 26854611 |
US |
52 | 2 |
Cytomegalovirus colitis, Anaemia, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, |
||||
| 518 | 26855027 |
GB |
2 | |
Thrombocytopenia, Anaemia, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, |
||||
| 519 | 26855097 |
EU |
48 | 1 |
Deep vein thrombosis, Presyncope, Nausea, Anaemia, |
||||
CAPECITABINE, CISPLATIN, PEMBROLIZUMAB, |
||||
| 520 | 26855148 |
JP |
2 | |
Death, Sepsis, Cardiac dysfunction, Myelosuppression, Malignant neoplasm progression, Deep vein thrombosis, Renal impairment, Infection, Pyrexia, Pyrexia, Anaemia, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, LENVATINIB, |
||||
| 521 | 26855169 |
GB |
1 | |
Anaemia, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, |
||||
| 522 | 26855237 |
EU |
85 | 2 |
Acute kidney injury, Anaemia, |
||||
PALBOCICLIB, ANASTROZOLE, |
||||
| 523 | 26855477 |
IL |
67 | |
Prostate cancer metastatic, Anaemia, Weight increased, Herpes zoster, Pollakiuria, Constipation, Asthenia, Full blood count decreased, |
||||
RUXOLITINIB, |
||||
| 524 | 26855510 |
CA |
78 | 2 |
Intestinal obstruction, Dyschezia, Crohn^s disease, Device issue, Stress, Faeces discoloured, Abnormal faeces, Drug ineffective, Anxiety, Faeces discoloured, Faeces hard, Breath odour, Dysgeusia, Haemorrhoidal haemorrhage, Fatigue, Anaemia, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, IRON, USTEKINUMAB, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, |
||||
| 525 | 26855640 |
66 | 2 | |
Anaemia, Haematuria, Hyponatraemia, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, NETUPITANT AND PALONOSETRON, FOSNETUPITANT AND PALONOSETRON, |
||||
| 526 | 26855791 |
US |
61 | 1 |
Pulmonary toxicity, Acute respiratory distress syndrome, Cachexia, Anaemia, Thrombocytopenia, Leukopenia, Acute kidney injury, Hyperkalaemia, Pulmonary oedema, Pulmonary alveolar haemorrhage, |
||||
CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 527 | 26855796 |
US |
72 | 2 |
Anaemia, Product use in unapproved indication, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PEMBROLIZUMAB, PREDNISONE, |
||||
| 528 | 26855799 |
EU |
63 | 2 |
Anaemia, COVID-19, |
||||
DOXORUBICIN, DOXORUBICIN, BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, DACARBAZINE, DACARBAZINE, |
||||
| 529 | 26855848 |
ID |
48 | 1 |
Cardiotoxicity, Atrial fibrillation, Palpitations, Supraventricular tachycardia, Atrial tachycardia, Atrial flutter, Left ventricular hypertrophy, Heart rate irregular, Leukocytosis, Anaemia, |
||||
CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 530 | 26855931 |
87 | 2 | |
Lower gastrointestinal haemorrhage, Anaemia, Acute kidney injury, |
||||
LINAGLIPTIN, AMLODIPINE BESYLATE, GLIPIZIDE, |
||||
| 531 | 26855938 |
71 | 1 | |
Renal impairment, Cerebrovascular accident, Anaemia, |
||||
| 532 | 26855964 |
81 | 2 | |
Constipation, Anaemia, Rectal haemorrhage, Haemorrhage, |
||||
EDOXABAN TOSYLATE, FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, TRAZODONE HYDROCHLORIDE, |
||||
| 533 | 26856176 |
EU |
66 | 1 |
Neutropenia, Thrombocytopenia, Leukopenia, Anaemia, |
||||
RYDAPT, |
||||
| 534 | 26856180 |
84 | ||
Anaemia, Off label use, |
||||
RUXOLITINIB, ANAGRELIDE, DARBEPOETIN ALFA, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROPEGINTERFERON ALFA-2B, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, FAMOTIDINE, MIRTAZAPINE, |
||||
| 535 | 26856282 |
BA |
57 | |
Anaemia, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, HYDROXYUREA, |
||||
| 536 | 26856284 |
IN |
1 | |
Toxicity to various agents, Transplant dysfunction, Septic shock, New onset diabetes after transplantation, COVID-19, Neutropenic sepsis, Hypertensive nephropathy, Anaemia, Vital functions abnormal, Breath sounds abnormal, Blood urea increased, Vitamin D abnormal, Transferrin abnormal, Glomerular filtration rate decreased, Haemoglobin abnormal, Goitre, Blood glucose abnormal, Body mass index increased, Heart rate increased, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, |
||||
| 537 | 26856507 |
CO |
63 | |
Thrombosis, Cardio-respiratory arrest, Nephropathy, Bone marrow disorder, Renal impairment, Platelet count decreased, Thyroid disorder, Blood creatinine increased, Renal disorder, Weight fluctuation, Blood calcium decreased, Anaemia, Off label use, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, ENALAPRIL, ENALAPRIL, VALSARTAN, VALSARTAN ORAL, |
||||
| 538 | 26856575 |
US |
51 | 1 |
Urinary retention, Haematuria, Flank pain, Urinary bladder haemorrhage, Tumour thrombosis, Anaemia, |
||||
| 539 | 26856636 |
JP |
8 | |
Malignant neoplasm progression, Anaemia, |
||||
TRIFLURIDINE AND TIPIRACIL, |
||||
| 540 | 26857089 |
JP |
77 | 1 |
Syncope, Anaemia, |
||||
IPTACOPAN, |
||||
| 541 | 26846740 |
US |
78 | 1 |
Anxiety, Appetite disorder, Arthralgia, Haemorrhage, Contusion, Respiratory tract congestion, Constipation, Cough, Cytopenia, Depression, Dizziness, Dysphagia, Dyspnoea, Dysuria, Oedema, Fatigue, Pyrexia, Alopecia, Headache, Deafness, Hot flush, Dyspepsia, Diarrhoea, Oedema peripheral, Paraesthesia, Anaemia, Myalgia, Nausea, Night sweats, Hypoaesthesia, Palpitations, Rash, Sleep disorder, Visual impairment, Vomiting, Weight decreased, Wheezing, Gastrooesophageal reflux disease, |
||||
LENALIDOMIDE, FOLIC ACID, CYANOCOBALAMIN, |
||||
| 542 | 26846808 |
EU |
||
Anaemia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, CARFILZOMIB, CARFILZOMIB, CARFILZOMIB, LENALIDOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MELPHALAN HYDROCHLORIDE, MELPHALAN, |
||||
| 543 | 26847088 |
CN |
74 | 1 |
Anaemia, Myelosuppression, Asthenia, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 544 | 26847111 |
EU |
46 | |
Pneumocystis jirovecii infection, Retroperitoneal cancer, Condition aggravated, Campylobacter bacteraemia, Immunodeficiency, COVID-19, Candida infection, Retroperitoneal mass, Mucosal inflammation, Respiratory tract infection, Escherichia urinary tract infection, Retroperitoneal lymphadenopathy, Blood immunoglobulin M decreased, Blood immunoglobulin A decreased, Anaemia, Viral infection, Fungal infection, Serum ferritin decreased, Acute sinusitis, Vascular purpura, Blood immunoglobulin G decreased, Clostridium test positive, Influenza, Lymphadenopathy, |
||||
RITUXIMAB, |
||||
| 545 | 26847258 |
EU |
60 | 1 |
Gastric ulcer haemorrhage, Anaemia, |
||||
ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYTARABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, IFOSFAMIDE, IFOSFAMIDE FOR INJECTION, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, RITUXIMAB, |
||||
| 546 | 26847410 |
JP |
77 | 2 |
Malignant neoplasm progression, Anaemia, |
||||
BELZUTIFAN, |
||||
| 547 | 26847580 |
JP |
1 | |
Malignant neoplasm progression, Anaemia, |
||||
BELZUTIFAN, |
||||
| 548 | 26847613 |
US |
64 | 2 |
Dizziness, Anaemia, |
||||
ABEMACICLIB, ABEMACICLIB, |
||||
| 549 | 26847690 |
US |
48 | 1 |
Pain, Hypokalaemia, Vitamin C deficiency, Contusion, Gingival bleeding, Dehydration, Body mass index decreased, Anaemia, Fatigue, Nausea, |
||||
BACLOFEN, GABAPENTIN, |
||||
| 550 | 26847779 |
US |
2 | |
Thrombosis, Anaemia, |
||||
IMLUNESTRANT, |
||||
| 551 | 26848041 |
EU |
90 | 1 |
Asthenia, Dizziness, Dyspnoea exertional, Exercise tolerance decreased, Anaemia, |
||||
EPLERENONE, |
||||
| 552 | 26848070 |
PK |
56 | 1 |
Renal tubular necrosis, Anaemia, Thrombocytopenia, Drug-induced liver injury, Tubulointerstitial nephritis, Renal tubular injury, |
||||
ISONIAZID, RIFAMPIN, PYRAZINAMIDE, |
||||
| 553 | 26848222 |
EU |
||
Anaemia, Abdominal wall haematoma, |
||||
RIVAROXABAN, QUETIAPINE, BISOPROLOL FUMARATE, FOLIC ACID, AMLODIPINE BESYLATE, FUROSEMIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CALCIFEDIOL, RASAGILINE MESYLATE, |
||||
| 554 | 26848284 |
EU |
4 | 2 |
Neutropenia, Skin infection, Thrombocytopenia, Hypogammaglobulinaemia, Leukopenia, Anaemia, Aspartate aminotransferase increased, Hypoalbuminaemia, Cytomegalovirus infection, Gamma-glutamyltransferase increased, Immunoglobulins decreased, Iron overload, Lymphopenia, |
||||
VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, BLINATUMOMAB, BLINATUMOMAB, BLINATUMOMAB, ETOPOSIDE, FLUDARABINE PHOSPHATE, THIOTEPA, |
||||
| 555 | 26848401 |
US |
79 | 1 |
Diarrhoea, Anaemia, |
||||
LENALIDOMIDE, ACYCLOVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, OXYCODONE, PREDNISONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, BORTEZOMIB, |
||||
| 556 | 26848477 |
EU |
2 | |
Erythema multiforme, Oral mucosal eruption, Osteolysis, Oral candidiasis, Hypocalcaemia, Hypokalaemia, Hypoalbuminaemia, Alanine aminotransferase increased, Constipation, Anaemia, Oedema, Stevens-Johnson syndrome, Vomiting, Nausea, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, ETOPOSIDE, ETOPOSIDE, PROPOFOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLINDAMYCIN HYDROCHLORIDE, HEPARIN SODIUM, MESNA, MESNA INJECTION, ALLOPURINOL, ALLOPURINOL, RANITIDINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE, POVIDONE-IODINE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, IFOSFAMIDE, IFOSFAMIDE FOR INJECTION, ALBUMIN HUMAN, ROCURONIUM BROMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYTARABINE, CYTARABINE, MESNA, MESNA INJECTION, BUPRENORPHINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BUPRENORPHINE HYDROCHLORIDE, HEPARIN SODIUM, ROCURONIUM BROMIDE, PROPOFOL, PROMETHAZINE HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, ALBUMIN HUMAN, DEXTROSE MONOHYDRATE, DEXTROSE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 557 | 26848656 |
EU |
10 | 1 |
Rectal haemorrhage, Anaemia, Metabolic acidosis, Hypoalbuminaemia, Rectal ulcer, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 558 | 26848699 |
EU |
91 | 1 |
Anaemia, Upper gastrointestinal haemorrhage, |
||||
DABIGATRAN ETEXILATE, AMLODIPINE BESYLATE, CANDESARTAN, |
||||
| 559 | 26849087 |
JP |
71 | 2 |
Skin ulcer, Scab, Dermatitis acneiform, Embolism venous, Anaemia, Dry skin, Ocular hyperaemia, |
||||
AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, GRANISETRON HYDROCHLORIDE, DEXAMETHASONE SODIUM PHOSPHATE, FAMOTIDINE, VONOPRAZAN FUMARATE, EDOXABAN TOSYLATE, |
||||
| 560 | 26849154 |
US |
29 | 2 |
Dialysis, Haptoglobin decreased, Blood lactate dehydrogenase increased, Bone pain, Hyperphosphataemia, Hypertension, White blood cell count increased, Vision blurred, Anaemia, Bone disorder, Blood parathyroid hormone increased, |
||||
CYSTEAMINE BITARTRATE, CINACALCET HYDROCHLORIDE, METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, |
||||
| 561 | 26849169 |
10 | 1 | |
Hypoalbuminaemia, Metabolic acidosis, Rectal ulcer, Rectal haemorrhage, Anaemia, Off label use, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 562 | 26849330 |
US |
57 | 2 |
Balance disorder, Rosacea, Pruritus, Anaemia, Red blood cell count decreased, Musculoskeletal chest pain, Flatulence, Tendonitis, Dizziness, Illness, Skin laceration, Palmar-plantar erythrodysaesthesia syndrome, Diarrhoea, |
||||
TUCATINIB, CAPECITABINE, |
||||
| 563 | 26849472 |
CA |
80 | 1 |
Anaemia, Abdominal distension, Abdominal pain, Activated partial thromboplastin time prolonged, Analgesic therapy, Malignant melanoma stage 0, Antacid therapy, Anticoagulant therapy, Aortic stenosis, Appendicitis, Appendicolith, Ascites, Aspartate aminotransferase increased, Aspiration, Asthenia, Asthma, Bacterial infection, Benign prostatic hyperplasia, Blood calcium increased, Blood cholesterol increased, Blood creatinine increased, Blood phosphorus increased, Blood test abnormal, Blood uric acid increased, Breath sounds abnormal, Bronchopulmonary aspergillosis allergic, Cardiogenic shock, Chronic obstructive pulmonary disease, Cardiovascular disorder, Congenital hiatus hernia, Constipation, Condition aggravated, Coronary artery disease, Diabetes mellitus, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug therapy, Dry mouth, Dyspnoea, End stage renal disease, Fatigue, Full blood count abnormal, Gastrointestinal disorder, General physical health deterioration, Headache, Gout, Hypercholesterolaemia, Hyperlipidaemia, Hyperphosphataemia, Hypertension, Hyponatraemia, Incorrect route of product administration, Hypophosphataemia, Intentional product misuse, Intentional product misuse, Iron deficiency, Joint injury, Liver disorder, Lower respiratory tract infection, Lung disorder, Micturition urgency, Multiple organ dysfunction syndrome, Musculoskeletal stiffness, Myasthenia gravis, Nausea, Neuralgia, Oedema peripheral, Off label use, Pain, Pleuritic pain, Product use in unapproved indication, Product dose omission issue, Pulmonary embolism, Pyrexia, Respiratory symptom, Sepsis, Sleep disorder, Sleep disorder therapy, Somnolence, Stress, Swelling, Thrombosis, Transaminases increased, Transient ischaemic attack, Tremor, Troponin increased, Ulcer, Upper respiratory tract infection, Ventricular fibrillation, Vomiting, |
||||
AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALLOPURINOL SODIUM, ALLOPURINOL SODIUM, ALLOPURINOL SODIUM, ALLOPURINOL SODIUM, DARBEPOETIN ALFA, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, DALTEPARIN SODIUM, DALTEPARIN SODIUM, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DEXLANSOPRAZOLE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DALTEPARIN SODIUM, DALTEPARIN SODIUM, MEPOLIZUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 564 | 26849490 |
JP |
62 | 2 |
Diverticulitis, Blood bilirubin increased, Anaemia, |
||||
DURVALUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, |
||||
| 565 | 26849513 |
EU |
68 | 2 |
Azotaemia, Hypokalaemia, Chronic kidney disease, Hypertensive nephropathy, Hypertension, Hydronephrosis, Urinary tract infection, Anaemia, Hyponatraemia, Metabolic acidosis, Proteinuria, Leukocyturia, Dehydration, Inflammation, Nitrite urine present, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROSUVASTATIN CALCIUM, AMLODIPINE, |
||||
| 566 | 26849564 |
EU |
12 | 2 |
Oral mucosal eruption, Osteolysis, Oral candidiasis, Hypocalcaemia, Hypokalaemia, Hypoalbuminaemia, Oedema, Alanine aminotransferase increased, Constipation, Anaemia, Nausea, Vomiting, Erythema multiforme, Stevens-Johnson syndrome, |
||||
CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CYTARABINE, CYTARABINE, PROPOFOL, ROCURONIUM BROMIDE, ALBUMIN HUMAN, IFOSFAMIDE, IFOSFAMIDE FOR INJECTION, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, POVIDONE-IODINE, PROMETHAZINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE, MESNA, MESNA INJECTION, HEPARIN SODIUM, ETOPOSIDE, ALLOPURINOL, COLISTIMETHATE SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, MESNA, MESNA INJECTION, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 567 | 26849584 |
|||
Medication error, Diarrhoea, Anaemia, |
||||
RIVAROXABAN, BISOPROLOL FUMARATE, AMLODIPINE, |
||||
| 568 | 26849761 |
EU |
81 | 1 |
Anaemia, Haematoma, Contraindication to medical treatment, |
||||
ENOXAPARIN SODIUM, DABIGATRAN ETEXILATE, |
||||
| 569 | 26850097 |
US |
2 | |
Deafness, Vitamin D deficiency, Anaemia, |
||||
INSULIN GLARGINE, |
||||
| 570 | 26850314 |
EU |
79 | 1 |
Haematuria, Anaemia, Leukopenia, Pneumonia, Syncope, Fatigue, Dyspnoea, Hypercreatininaemia, |
||||
CARBOPLATIN, ATEZOLIZUMAB, ETOPOSIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 571 | 26850410 |
EU |
48 | 1 |
Presyncope, Deep vein thrombosis, Nausea, Anaemia, |
||||
CISPLATIN, PEMBROLIZUMAB, CAPECITABINE, |
||||
| 572 | 26850478 |
US |
79 | 1 |
Diarrhoea, Anaemia, |
||||
LENALIDOMIDE, ACYCLOVIR, ALPRAZOLAM, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FAMOTIDINE, HYDROCHLOROTHIAZIDE, CANAGLIFLOZIN, LISINOPRIL, |
||||
| 573 | 26850520 |
US |
2 | |
Anaemia, Diabetic ketoacidosis, Sepsis, Urinary tract infection, Red blood cell count decreased, Reticulocyte count decreased, |
||||
CAPIVASERTIB, |
||||
| 574 | 26850895 |
IR |
15 | 1 |
Product ineffective for unapproved use, Myelosuppression, Thrombocytopenia, Anaemia, Suspected off label use, |
||||
METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MEROPENEM, MEROPENEM, ETANERCEPT, ETANERCEPT, FLUCONAZOLE, FLUCONAZOLE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HUMAN IMMUNOGLOBULIN G, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, ACYCLOVIR, ACYCLOVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 575 | 26850931 |
EU |
80 | 1 |
Intentional product misuse, Bacterial infection, Drug hypersensitivity, Dyspnoea, Iron deficiency, Anaemia, Blood cholesterol increased, Blood uric acid increased, Stress, Hyponatraemia, Blood phosphorus increased, Somnolence, Appendicitis, Appendicolith, Ascites, Abdominal distension, Abdominal pain, Cardiogenic shock, Constipation, Chronic obstructive pulmonary disease, Diabetes mellitus, Drug intolerance, General physical health deterioration, Hypophosphataemia, Multiple organ dysfunction syndrome, Myasthenia gravis, Nausea, Neuralgia, Pulmonary embolism, Sepsis, Dry mouth, Sleep disorder, Swelling, Thrombosis, Vomiting, Off label use, Activated partial thromboplastin time prolonged, Iron deficiency anaemia, Aortic stenosis, Bacteroides infection, Blood calcium increased, Hyperlipidaemia, Blood creatinine increased, Blood test abnormal, Condition aggravated, Drug hypersensitivity, Drug ineffective, End stage renal disease, Gout, Hypertension, Inappropriate schedule of product administration, Intentional product misuse, Incorrect route of product administration, Lower respiratory tract infection, Lung opacity, Musculoskeletal stiffness, Oedema peripheral, Pleural effusion, Pneumonia, Troponin increased, Ulcer, Ventricular fibrillation, Somnolence, Total lung capacity decreased, |
||||
GABAPENTIN, HYDROMORPHONE HYDROCHLORIDE, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, RAMIPRIL, SIMVASTATIN, SIMVASTATIN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, PHYTONADIONE, MAGNESIUM OXIDE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DOBUTAMINE, CALCIUM CARBONATE, ANTACID, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR ACID, OSELTAMIVIR, INSULIN DEGLUDEC, VITAMIN E, SODIUM FERRIC GLUCONATE COMPLEX, SODIUM FERRIC GLUCONATE COMPLEX, SODIUM FERRIC GLUCONATE COMPLEX, SODIUM FERRIC GLUCONATE COMPLEX, SODIUM CITRATE, SODIUM CITRATE, MAGNESIUM CARBONATE, HEPARIN SODIUM AND DEXTROSE, HEPARIN SODIUM AND DEXTROSE, SODIUM FERRIC GLUCONATE COMPLEX, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALLANTOIN, MEDICINAL MASSAGE OIL, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALUMINUM HYDROXIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMLODIPINE, AMLODIPINE, AMMONIUM CHLORIDE, DARBEPOETIN ALFA, ASCORBIC ACID, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, BISMUTH SUBNITRATE, BISMUTH SUBSALICYLATE, |
||||
| 576 | 26850988 |
EU |
2 | |
Hepatotoxicity, Myalgia, Paronychia, Nausea, Fatigue, Anaemia, Thrombocytopenia, Transaminases increased, |
||||
PEMETREXED, PEMETREXED DISODIUM, OSIMERTINIB, CARBOPLATIN, |
||||
| 577 | 26850994 |
US |
||
Fatigue, Anaemia, |
||||
RUXOLITINIB, |
||||
| 578 | 26851029 |
56 | 1 | |
Platelet count decreased, Anaemia, Malignant neoplasm of ampulla of Vater, |
||||
| 579 | 26851061 |
QA |
2 | |
Breast cancer recurrent, Malignant neoplasm progression, Anaemia, |
||||
ABEMACICLIB, ABEMACICLIB, |
||||
| 580 | 26851066 |
US |
1 | |
Anaemia, |
||||
RISANKIZUMAB-RZAA, |
||||
| 581 | 26851363 |
US |
72 | 2 |
Dyspnoea, Fatigue, Anaemia, Hypertension, Gait inability, Impaired quality of life, Illness, |
||||
BIMEKIZUMAB, FERROUS SULFATE, |
||||
| 582 | 26846507 |
CO |
71 | 2 |
Anaemia, Weight decreased, Fall, Pain, Decreased appetite, Gait disturbance, |
||||
EVOLOCUMAB, |
||||
| 583 | 26846602 |
EU |
73 | |
Anaemia, |
||||
BEVACIZUMAB, OLAPARIB, |
||||
| 584 | 26846670 |
JP |
1 | |
Lymphangiosis carcinomatosa, Malaise, Anaemia, |
||||
BELZUTIFAN, |
||||
| 585 | 26844996 |
EU |
10 | 1 |
Rectal haemorrhage, Rectal ulcer, Anaemia, Metabolic acidosis, Hypoalbuminaemia, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OCTREOTIDE ACETATE, OCTREOTIDE, POLYETHYLENE GLYCOL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, |
||||
| 586 | 26845005 |
US |
70 | 2 |
Gastrointestinal tube insertion, Anaemia, Impaired gastric emptying, Feeding disorder, Transfusion, |
||||
RISANKIZUMAB-RZAA, |
||||
| 587 | 26845097 |
AU |
1 | |
Squamous cell carcinoma, Skin graft, Anaemia, |
||||
| 588 | 26845581 |
JP |
70 | 2 |
Prosthetic valve endocarditis, Anaemia, Headache, C-reactive protein increased, Rhinorrhoea, Generalised oedema, Musculoskeletal stiffness, Blood test abnormal, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, WARFARIN, RIOCIGUAT, TOLVAPTAN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MACITENTAN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, EMPAGLIFLOZIN, CARVEDILOL, TOLVAPTAN, FUROSEMIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ROSUVASTATIN, URSODIOL, URSOSIOL, ROMOSOZUMAB-AQQG, |
||||
| 589 | 26845601 |
US |
84 | 1 |
Anaemia, Haematuria, |
||||
RIVAROXABAN, |
||||
| 590 | 26839589 |
EU |
74 | 2 |
Gastrointestinal disorder, Anaemia, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, AVACOPAN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, |
||||
| 591 | 26839808 |
US |
75 | 2 |
Neoplasm malignant, Fatigue, Brain fog, Anaemia, Blood iron decreased, Asthma, Cough, |
||||
DUPILUMAB, |
||||
| 592 | 26839883 |
EU |
53 | 2 |
Anaemia, |
||||
| 593 | 26839930 |
JP |
79 | 1 |
Malignant neoplasm progression, Anaemia, |
||||
BELZUTIFAN, |
||||
| 594 | 26840028 |
GB |
||
Medication error, Dumping syndrome, Diarrhoea, Anaemia, |
||||
RIVAROXABAN, BISOPROLOL FUMARATE, AMLODIPINE, |
||||
| 595 | 26840056 |
US |
2 | |
Heavy menstrual bleeding, Anaemia, |
||||
REMIBRUTINIB, |
||||
| 596 | 26840137 |
CA |
1 | |
Leukopenia, Neutropenia, Red blood cell count decreased, Haemoglobin decreased, Haematocrit decreased, Mean cell volume increased, Gastrointestinal injury, Anaemia, Liver injury, |
||||
UPADACITINIB, |
||||
| 597 | 26840469 |
US |
65 | 1 |
Thrombocytopenia, Thrombotic microangiopathy, Anaemia, Product dispensing error, |
||||
ECULIZUMAB, |
||||
| 598 | 26840532 |
EU |
60 | |
Gastric ulcer haemorrhage, Anaemia, Suspected off label use, |
||||
RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, IFOSFAMIDE, IFOSFAMIDE FOR INJECTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYTARABINE, VINCRISTINE SULFATE, ETOPOSIDE, |
||||
| 599 | 26840536 |
EU |
77 | 2 |
Anaemia, Aphthous ulcer, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, DOCETAXEL, DOCETAXEL ANHYDROUS, OXALIPLATIN, |
||||
| 600 | 26840558 |
JP |
70 | 1 |
Malignant neoplasm progression, Anaemia, |
||||
BELZUTIFAN, BELZUTIFAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
